BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

NCT00014547 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: BBR 3464

Sponsor

Theradex